Cyclerion Therapeutics (CYCN) Cash from Investing Activities Growth (1y) (2019 - 2021)
Cyclerion Therapeutics (CYCN) Cash from Investing Activities Growth (1y) (2019 - 2021) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Cyclerion Therapeutics |
11.94 Mn |
8.70 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2021 |
-333.33% |
| Jun 30, 2021 |
103.08% |
| Mar 31, 2021 |
207.82% |
| Dec 31, 2020 |
1,536.00% |
| Sep 30, 2020 |
100.54% |
| Jun 30, 2020 |
98.47% |
| Mar 31, 2020 |
25.25% |
| Dec 31, 2019 |
94.49% |
| Sep 30, 2019 |
52.24% |
| Jun 30, 2019 |
-1,315.67% |
| Mar 31, 2019 |
-1,019.75% |
